Molecular cancer therapeutics

Subtype-specific MEK-PI3 kinase feedback as a therapeutic target in pancreatic adenocarcinoma.

Molecular cancer therapeutics

Mirzoeva OK, Collisson EA, Schaefer PM, Hann B, Hom YK, Ko AH, Korn WM

Synthetic lethal targeting of PTEN-deficient cancer cells using selective disruption of polynucleotide kinase/phosphatase.

Molecular cancer therapeutics

Mereniuk TR, El Gendy MA, Mendes-Pereira AM, Lord CJ, Ghosh S, Foley E, Ashworth A, Weinfeld M

Synthetic lethal targeting of PTEN-deficient cancer cells using selective disruption of polynucleotide kinase/phosphatase.

Molecular cancer therapeutics

Mereniuk TR, El Gendy MA, Mendes-Pereira AM, Lord CJ, Ghosh S, Foley E, Ashworth A, Weinfeld M

Antitumor mechanisms of targeting the PDK1 pathway in head and neck cancer.

Molecular cancer therapeutics

Bhola NE, Freilino ML, Joyce SC, Sen M, Thomas SM, Sahu A, Cassell A, Chen CS, Grandis JR

Antitumor mechanisms of targeting the PDK1 pathway in head and neck cancer.

Molecular cancer therapeutics

Bhola NE, Freilino ML, Joyce SC, Sen M, Thomas SM, Sahu A, Cassell A, Chen CS, Grandis JR

Expression and silencing of the microtubule-associated protein Tau in breast cancer cells.

Molecular cancer therapeutics

Spicakova T, O'Brien MM, Duran GE, Sweet-Cordero A, Sikic BI

Expression and silencing of the microtubule-associated protein Tau in breast cancer cells.

Molecular cancer therapeutics

Spicakova T, O'Brien MM, Duran GE, Sweet-Cordero A, Sikic BI

Organic cation transporters modulate the uptake and cytotoxicity of picoplatin, a third-generation platinum analogue.

Molecular cancer therapeutics

More SS, Li S, Yee SW, Chen L, Xu Z, Jablons DM, Giacomini KM

Pages